CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		126,938,102
Beginning balance at Dec. 31, 2023	$ 717,547	$ 126	$ 0	$ 1,162,993	$ (26,777)	$ (418,795)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		47,583
Exercise of stock options	280			280
Vesting of restricted stock units (in shares)		1,347,681
Stock-based compensation	20,579			20,579
Foreign currency translation adjustments	(1,812)				(1,812)
Net income (loss)	(20,524)					(20,524)
Ending balance (in shares) at Mar. 31, 2024		128,333,366
Ending balance at Mar. 31, 2024	716,070	$ 126	0	1,183,852	(28,589)	(439,319)
Beginning balance (in shares) at Dec. 31, 2024		129,332,030
Beginning balance at Dec. 31, 2024	715,983	$ 125	(741)	1,269,264	(30,060)	(522,605)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units (in shares)		2,424,209
Vesting of restricted stock units	0		741	(741)
Stock-based compensation	24,395			24,395
Foreign currency translation adjustments	6,315				6,315
Net income (loss)	529					529
Ending balance (in shares) at Mar. 31, 2025		131,756,239
Ending balance at Mar. 31, 2025	$ 747,222	$ 125	$ 0	$ 1,292,918	$ (23,745)	$ (522,076)